SPN and Parkinson disease: Although it remains unknown whether transcriptionally separated SPN groups also have distinct morphological or physiological phenotypes, it seems possible that preexisting molecular differences between dSPNs underlie the segregation of responses observed after L-DOPA treatment in this animal model of PD.